Search
FAV-201
go.drugbank.com/drugs/DB06130ExperimentalFAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.
N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
go.drugbank.com/drugs/DB06940ExperimentalN-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide is a solid. This compound belongs to the pyrrolotriazines. … N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide is known to target mitogen-activated protein kinase 14.
Synonyms: N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamideSC 41930
go.drugbank.com/drugs/DB17101ExperimentalCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalTiaramide
go.drugbank.com/drugs/DB20499ExperimentalTiaramide is a small molecule drug. Tiaramide has a monoisotopic molecular weight of 355.08 Da.
Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalMaplirpacept
go.drugbank.com/drugs/DB18441InvestigationalMaplirpacept is a recombinant fusion protein consisting of the CD47-binding domain of human signal regulatory protein alpha (SIRPa) linked to the IgG4 Fc region of human IgG.
Varespladib methyl
go.drugbank.com/drugs/DB05737InvestigationalStudies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Alethine
go.drugbank.com/drugs/DB05800InvestigationalIt belongs to a family of chemicals called disulfides. It is a low molecular weight disulfide that has been shown to exhibit in vivo antitumor activity in murine myeloma and melanoma models.
Sulfaquinoxaline
go.drugbank.com/drugs/DB11464ExperimentalVet approvedSulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as
Ravagalimab
go.drugbank.com/drugs/DB16676InvestigationalRavagalimab is under investigation in clinical trial NCT03695185 (A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe It Is in Participants With Moderate to Severe Ulcerative Colitis